Brief: Shenzhen Hepalink Pharmaceutical To Issue Corporate Bonds Worth Not Exceeding RMB1.50 Bln
10/12/2021 14:13
Dec 10 (Reuters) - Shenzhen Hepalink Pharmaceutical Group Co
Ltd 002399.SZ :
* TO ISSUE CORPORATE BONDS WITH A TOTAL PRINCIPAL AMOUNT NOT
EXCEEDING RMB1.50 BILLION
Further company coverage: 002399.SZ
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Shenzhen Hepalink Pharmaceutical
See all newsBrief: HEPALINK 9M Revenue RMB3,796.9 Million
Brief: Shenzhen Hepalink Pharmaceutical Group Says Enoxaparin Sodium Injection Obtains New Manufacturer Authorization From EMA
Brief: Shenzhen Hepalink Pharmaceutical Group Posts QTRLY Net Profit Attributable Of RMB156.6 Million
Brief: Shenzhen Hepalink Pharmaceutical Posts Profit Attributable RMB646.7 Million For Year
Brief: Shenzhen Hepalink Pharmaceutical Says Enoparin Approved In Argentina